81
44
Growth Score
-8 pts
Heat Score
-6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
1937520
Roxane Laboratories engages in the research, development, manufacture, marketing, sale, and distribution of generic pharmaceuticals.
Randy Wilson: President and CEOPast Role: Pfizer, Manager of Clinical Manufacturing
About the Company
Roxane Laboratories, Inc., a specialty generics company, engages in the research, development, manufacture, marketing, sale, and distribution of generic pharmaceuticals in the United States. It markets a portfolio of 111 products in seven dosage forms, including immediate-release solids, nasal sprays, liquids, and sublingual tablet products. The
company’s marketed products primarily include fluticasone, buprenorphine, methotrexate, prednisone, and calcium acetate.
